Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Catalent announced the BSI has awarded Catalent a global accreditation against the international management standards for environment and Occupational Safety.
read more
Monday, November 28, 2016
Catalent has agreed to acquire Accucaps Industries Limited (Accucaps), the Canada-based developer and manufacturer of Over-the-Counter (OTC), high potency and conventional pharmaceutical softgels. Financial details of the transaction have not been ...
read more
Catalent has acquired Promethera’s cell therapy manufacturing subsidiary, Hepatic Cell Therapy Support SA, including its 32,400 square-foot facility in Gosselies, Belgium.
read more
Catalent has acquired from Erytech Pharma its state-of-the-art, commercial-scale cell therapy manufacturing facility in Princeton, New Jersey, for $44.5 million.
read more
Catalent announced a deal to acquire a clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan, from Teva-Takeda.
read more
Thursday, September 22, 2022
Catalent, a leader in enabling biopharma, cell, gene, and consumer health partners to optimize the development, launch, and supply of better patient treatments across multiple modalities, announced that it has reached an agreement to acquire Metrics ...
read more
Wednesday, November 19, 2014
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has acquired Micron Technologies, a leading global ...
read more
Thursday, October 01, 2020
Catalent has acquired a new manufacturing facility in Bloomington, Indiana, to create a North American center of excellence.
read more
Catalent expanded services and capabilities at its facility in Shiga, Japan, to include the storage, kitting, and distribution of advanced therapies at ultra-low temperatures for clinical trials.
read more
Catalent announced today that it has made an investment to expand capabilities at its clinical supply services facility in Philadelphia to support sponsors developing cell and gene therapies.
read more
Catalent will expand its Argentinian site in Loma Hermosa, Buenos Aires.
read more
Catalent Pharma Solutions, a leading supplier of inhalation drug development, delivery and supply capabilities, today announced that it has entered into a contract with Biota Pharmaceuticals, Inc. (“Biota”), to develop and provide filling and ...
read more
Thursday, January 12, 2023
Catalent and Ethicann Pharmaceuticals Inc. announced that the companies have executed a development and license agreement to develop Ethicann’s clinical drug pipeline using Catalent’s proprietary Zydis® orally disintegrating tablet (ODT) technology.
read more
Wednesday, March 15, 2023
Catalent and Grünenthal announced their successful formulation design and clinical-phase manufacturing collaboration for an orally dosed small molecule in Grünenthal's pipeline.
Positive preclinical results from the molecule have allowed Grünenthal ...
read more
Wednesday, August 27, 2014
Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is collaborating with privately held Australian biomarker research company, ...
read more